Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ATRO +12.7%, OPFI +10.2%, SWIM +9%, REVG +6.2%, DIN +4.6%, INGM +4.5% (also initiates dividend; also $75 mln share repurchase plan in connection Imola JV), EC +3.8%, CTOS +3.2%, TXO +3%, FLUT +1.4%, FL +1%, RSKD +0.8%
Other news:
- IVVD +11.4% (clinically meaningful in vitro neutralization data for PEMGARDA)
- MRNA +9% (CEO bought $5 mln in shares)
- EOSE +7.9% (names new CFO)
- MULN +7% (stock offering by selling shareholders)
- CIFR +5.1% (February operational update)
- ACI +4.3% (to join S&P MidCap 400)
- FIP +3.1% (to delay 10-K filing)
- LOB +2.9% (to delay 10-K filing)
- CMRX +2.8% (to be acquired by Jazz Pharmaceuticals (JAZZ) for $8.55 per share)
- CMBT +2.7% (CMBT acquires stake in GOGL)
- IONQ +2.7% (significant milestone in the development of high-speed, mixed-species quantum logic gates for trapped-ion quantum computing and networking)
- TS +1.8% (completes its $700 mln stock buyback program)
- WH +1.7% (increases dividend)
- DNTH +1.6% (Strengthens Strategic Commercial Leadership)
- ARM +1.6% (will receive $250 mln from Malaysia for design blueprints)
- DLTR +1.2% (announced that Stewart Glendinning will become the company's next CFO effective March 30)
- PAC +1.1% (Feb traffic)